BMY
Bristol-Myers Squibb Co.
Company · XNYS · US · USD
Market price
$65.06
+$9.39 (+16.87%) · 3 months
| Date and time | Price |
|---|---|
| May 11, 2026 | $55.67 |
| May 12, 2026 | $55.87 |
| May 13, 2026 | $56.18 |
| May 14, 2026 | $56.43 |
| May 15, 2026 | $56.73 |
| May 18, 2026 | $57.31 |
| May 19, 2026 | $57.29 |
| May 20, 2026 | $58.58 |
| May 21, 2026 | $58.43 |
| May 22, 2026 | $59.98 |
| May 26, 2026 | $58.03 |
| May 27, 2026 | $57.53 |
| May 28, 2026 | $56.90 |
| May 29, 2026 | $57.18 |
| Jun 1, 2026 | $54.95 |
| Jun 2, 2026 | $54.46 |
| Jun 3, 2026 | $54.74 |
| Jun 4, 2026 | $56.66 |
| Jun 5, 2026 | $57.27 |
| Jun 8, 2026 | $55.57 |
| Jun 9, 2026 | $56.48 |
| Jun 10, 2026 | $55.60 |
| Jun 11, 2026 | $56.90 |
| Jun 12, 2026 | $57.13 |
| Jun 15, 2026 | $56.24 |
| Jun 16, 2026 | $55.92 |
| Jun 17, 2026 | $55.28 |
| Jun 18, 2026 | $54.00 |
| Jun 22, 2026 | $54.70 |
| Jun 23, 2026 | $55.53 |
| Jun 24, 2026 | $55.00 |
| Jun 25, 2026 | $55.39 |
| Jun 26, 2026 | $57.52 |
| Jun 29, 2026 | $58.56 |
| Jun 30, 2026 | $57.62 |
| Jul 1, 2026 | $56.44 |
| Jul 2, 2026 | $58.13 |
| Jul 6, 2026 | $56.70 |
| Jul 7, 2026 | $57.97 |
| Jul 8, 2026 | $57.54 |
| Jul 9, 2026 | $57.94 |
| Jul 10, 2026 | $57.58 |
| Jul 13, 2026 | $59.34 |
| Jul 14, 2026 | $56.95 |
| Jul 15, 2026 | $58.72 |
| Jul 16, 2026 | $60.51 |
| Jul 17, 2026 | $60.74 |
| Jul 20, 2026 | $60.16 |
| Jul 21, 2026 | $60.93 |
| Jul 22, 2026 | $60.76 |
| Jul 23, 2026 | $61.51 |
| Jul 24, 2026 | $62.09 |
| Jul 27, 2026 | $62.56 |
| Jul 28, 2026 | $63.60 |
| Jul 29, 2026 | $63.10 |
| Jul 30, 2026 | $64.86 |
| Jul 31, 2026 | $65.31 |
| Aug 3, 2026 | $65.47 |
| Aug 4, 2026 | $65.89 |
| Aug 5, 2026 | $63.63 |
| Aug 6, 2026 | $64.15 |
| Aug 7, 2026 | $64.72 |
| Aug 10, 2026 | $65.06 |
- Period change
- +16.87%
- Period low
- $54.00
- Period high
- $65.89
- Observations
- 63
- Updated
- Aug 10, 2026, 6:28 PM
About Bristol-Myers Squibb Co.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Company websiteClassifications
- Biotechnology · Biotech
- Pharmaceuticals · Pharma
- Healthcare
Market details
- Type
- Company
- Market
- XNYS
- Operating market
- XNYS
- Country
- US
- Currency
- USD
- Market capitalization
- $133,409,694,183.36
- Employees
- 32.5K